COVID-19: how to proceed with the practice of plastic surgery in Brazil. What do we know right now?

Abstract

1 Hospital São Luiz Itaim, São Paulo, SP, Brazil. 2 Faculdade de Medicina do ABC, Plastic Surgery Department, São Paulo, SP, Brazil. 3 University of the São Paulo, Clinical Immunology and Allergy Division, São Paulo, SP, Brazil. Conflicts of interest: none. COVID-19 (coronavirus disease, described in 2019) is an infectious disease caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Most confirmed cases are mild or asymptomatic, but the most severe cases can progress to severe pneumonia with respiratory failure and death. In Brazil, there is a scenario of an exponential increase in cases, making it challenging to identify the source of contagion. We cannot yet specify when the peak of the COVID-19 outbreak will occur in our country or when the numbers of new contaminants and deaths will begin to decrease. So, the most important thing is protection against a virus for which all the details about contagion, transmission, and treatment are not known. The pandemic impacted and modified medical care, especially for surgical specialties, where face-to-face care is essential and cannot be replaced entirely by telemedicine. Thus, this review aimed to compile theoretical and practical aspects regarding the pandemic COVID-19 and its impact on plastic surgery activity routine. Protocols are proposed for resuming our routines, analyzing countries’ experience at an advanced stage of the pandemic. ■ ABSTRACT